OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial

Joaquin A. Vizcarra, Jose Ricardo Lopez-Castellanos, Alok K. Dwivedi, David A. Schmerler, Scott Ries, Alberto J. Espay

Open source

DOI
10.1016/j.parkreldis.2019.02.009
Published
2019-06
Container
Parkinsonism & Related Disorders
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.parkreldis.2019.02.009,
  title = {OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial},
  author = {Joaquin A. Vizcarra and Jose Ricardo Lopez-Castellanos and Alok K. Dwivedi and David A. Schmerler and Scott Ries and Alberto J. Espay},
  year = {2019},
  journal = {Parkinsonism \& Related Disorders},
  doi = {10.1016/j.parkreldis.2019.02.009},
  url = {https://doi.org/10.1016/j.parkreldis.2019.02.009}
}

RIS

TY  - JOUR
TI  - OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial
AU  - Joaquin A. Vizcarra
AU  - Jose Ricardo Lopez-Castellanos
AU  - Alok K. Dwivedi
AU  - David A. Schmerler
AU  - Scott Ries
AU  - Alberto J. Espay
PY  - 2019
JO  - Parkinsonism & Related Disorders
DO  - 10.1016/j.parkreldis.2019.02.009
UR  - https://doi.org/10.1016/j.parkreldis.2019.02.009
ER  - 

APA

Vizcarra, J. A., Lopez-Castellanos, J. R., Dwivedi, A. K., Schmerler, D. A., Ries, S., & Espay, A. J. (2019). OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial. Parkinsonism & Related Disorders. https://doi.org/10.1016/j.parkreldis.2019.02.009

Source records